the extrapulmonary effects of slow-release theophylline and an inhaled beta 2-agonist ( albuterol ) were examined separately and in combination among 18 adults and adolescents with asthma during a 3-month randomized , double-blind , crossover trial .
C0039771
theophylline
C0004096
asthma